MedTrace Logo

Study Assessing the Safety and Performance of Smart Matrix®

NCT03742726 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2021-02-21

No results posted yet for this study

Summary

Smart Matrix is a sterile, single layer dermal replacement scaffold. The scaffold consists of a porous matrix of cross-linked human fibrin plus alginate that has been designed and optimised to facilitate wound closure and healing through cellular invasion.

Conditions

Interventions

DEVICE

Smart Matrix scaffold

Smart Matrix dermal replacement scaffold

Sponsors & Collaborators

  • Smart Matrix Limited

    lead OTHER

Principal Investigators

  • Baljit Dheansa, MBBS FRCS · Queen Victoria Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-12
Primary Completion
2021-07-31
Completion
2022-01-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03742726 on ClinicalTrials.gov